Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FERMENTA BIOTECH vs BAFNA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FERMENTA BIOTECH BAFNA PHARMA FERMENTA BIOTECH/
BAFNA PHARMA
 
P/E (TTM) x 119.7 466.1 25.7% View Chart
P/BV x 3.5 2.3 148.8% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 FERMENTA BIOTECH   BAFNA PHARMA
EQUITY SHARE DATA
    FERMENTA BIOTECH
Mar-24
BAFNA PHARMA
Mar-24
FERMENTA BIOTECH/
BAFNA PHARMA
5-Yr Chart
Click to enlarge
High Rs214126 170.5%   
Low Rs10477 135.9%   
Sales per share (Unadj.) Rs116.364.4 180.4%  
Earnings per share (Unadj.) Rs-8.33.1 -267.8%  
Cash flow per share (Unadj.) Rs0.25.2 4.7%  
Dividends per share (Unadj.) Rs1.250-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs95.634.2 279.9%  
Shares outstanding (eoy) m28.8723.66 122.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.6 87.3%   
Avg P/E ratio x-19.132.5 -58.8%  
P/CF ratio (eoy) x646.219.4 3,337.3%  
Price / Book Value ratio x1.73.0 56.2%  
Dividend payout %-15.00-   
Avg Mkt Cap Rs m4,5912,390 192.1%   
No. of employees `000NANA-   
Total wages/salary Rs m585190 307.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,3571,525 220.2%  
Other income Rs m11835 335.3%   
Total revenues Rs m3,4751,560 222.8%   
Gross profit Rs m205111 184.2%  
Depreciation Rs m24750 494.9%   
Interest Rs m17423 760.9%   
Profit before tax Rs m-9973 -134.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1410-   
Profit after tax Rs m-24073 -326.7%  
Gross profit margin %6.17.3 83.7%  
Effective tax rate %-143.20-   
Net profit margin %-7.24.8 -148.4%  
BALANCE SHEET DATA
Current assets Rs m2,626945 277.9%   
Current liabilities Rs m1,941541 358.8%   
Net working cap to sales %20.426.5 77.0%  
Current ratio x1.41.7 77.5%  
Inventory Days Days262 1,456.1%  
Debtors Days Days7591,087 69.9%  
Net fixed assets Rs m2,937532 551.9%   
Share capital Rs m144237 61.0%   
"Free" reserves Rs m2,617572 457.6%   
Net worth Rs m2,761808 341.6%   
Long term debt Rs m425108 395.6%   
Total assets Rs m5,5631,477 376.7%  
Interest coverage x0.44.2 10.3%   
Debt to equity ratio x0.20.1 115.8%  
Sales to assets ratio x0.61.0 58.4%   
Return on assets %-1.26.5 -18.1%  
Return on equity %-8.79.1 -95.7%  
Return on capital %2.410.5 22.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,2070-   
Fx outflow Rs m00-   
Net fx Rs m1,2070-   
CASH FLOW
From Operations Rs m1,05395 1,110.7%  
From Investments Rs m-155-151 102.9%  
From Financial Activity Rs m-909-8 10,751.7%  
Net Cashflow Rs m-10-64 15.6%  

Share Holding

Indian Promoters % 54.5 88.3 61.7%  
Foreign collaborators % 7.6 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 37.9 11.7 324.3%  
Shareholders   13,221 7,295 181.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FERMENTA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on DIL LIMITED vs BAFNA PHARM.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

DIL LIMITED vs BAFNA PHARM. Share Price Performance

Period DIL LIMITED BAFNA PHARM. S&P BSE HEALTHCARE
1-Day -1.31% -0.04% 0.11%
1-Month 9.46% 1.68% -3.22%
1-Year 109.32% -8.10% 42.65%
3-Year CAGR 6.31% -14.14% 19.86%
5-Year CAGR 9.06% 72.42% 25.90%

* Compound Annual Growth Rate

Here are more details on the DIL LIMITED share price and the BAFNA PHARM. share price.

Moving on to shareholding structures...

The promoters of DIL LIMITED hold a 62.1% stake in the company. In case of BAFNA PHARM. the stake stands at 88.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DIL LIMITED and the shareholding pattern of BAFNA PHARM..

Finally, a word on dividends...

In the most recent financial year, DIL LIMITED paid a dividend of Rs 1.3 per share. This amounted to a Dividend Payout ratio of -15.0%.

BAFNA PHARM. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of DIL LIMITED, and the dividend history of BAFNA PHARM..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.